Gonadotropic pituitary carcinoma: HER-2/neu expression and gene amplification
Federico Roncaroli(Manchester Academic Health Science Centre), Jonathan A. Fletcher(Harvard University), Éva Horváth, William F. Young(Mayo Clinic in Arizona), Kálmán Kovács, Mary C. Bishop, Ricardo V. Lloyd(University of Wisconsin–Madison), Bradley Hsi, Bernd W. Scheithauer(Mayo Clinic), Vânia Nosé(Massachusetts General Hospital)
Cited by 43
Related Papers
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
|Journal of Clinical Oncology|2006|725
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716